Scott A. Lang, President and CEO of Anterix Inc., filed an amended Form 4/A on September 23, 2026, disclosing the sale of 15,000 shares of common stock on September 21, 2026, and clarifying that the transaction was executed under a Rule 10b5-1(c) trading plan.
Key Highlights
- Sale date: Scott A. Lang disposed of 15,000 shares of Anterix common stock on September 21, 2026.
- Sale price: Shares were sold at $80 per share, according to the filing.
- Remaining ownership: Following the transaction, Lang directly held 26,470 shares of common stock.
- 10b5-1 plan: The amendment was filed to indicate the sale was made pursuant to a Rule 10b5-1(c) trading plan adopted on June 22, 2026.
- Reporting person role: Lang is identified in the filing as both a Director and President and CEO of Anterix Inc.
Anterix CEO's Share Sale Attributed to Pre-Established Trading Plan
Scott A. Lang, President and CEO and a Director of Anterix Inc. (NASDAQ:ATEX), filed an amended statement of changes in beneficial ownership on September 23, 2026. The amendment, a Form 4/A, corrects the original filing dated September 22, 2026, to reflect that the reported transaction was carried out under a Rule 10b5-1(c) trading plan.
According to the filing, Lang sold 15,000 shares of Anterix common stock on September 21, 2026, at a price of $80 per share. The transaction was coded as a sale ("S") and recorded as a disposition ("D") of directly held securities. Following the sale, the filing reports that Lang directly beneficially owned 26,470 shares of common stock. No derivative securities transactions were reported in the filing.
The filing states in its explanation of responses that "this Form 4 is being amended to indicate that the transaction reported herein was effected pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on June 22, 2026." The form was signed by Gena L. Ashe as Attorney-in-Fact on September 23, 2026. The filing also indicates the box was checked to confirm the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
What Was Disclosed
The amended Form 4/A discloses a September 21, 2026, sale of 15,000 Anterix common shares at $80 per share by CEO Scott A. Lang, and clarifies the sale was executed under a Rule 10b5-1(c) plan adopted on June 22, 2026, leaving Lang with 26,470 directly held shares.



Please wait processing your request...